Phosphorylation-dependent interactions between ADAM15 cytoplasmic domain and Src family protein-tyrosine kinases

被引:91
作者
Poghosyan, Z
Robbins, SM
Houslay, MD
Webster, A
Murphy, G
Edwards, DR [1 ]
机构
[1] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England
[2] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada
[3] Univ Glasgow, Div Biochem & Mol Biol, Glasgow G12 8QQ, Lanark, Scotland
[4] Celltech Therapeut Ltd, Slough SK1 4EN, Berks, England
关键词
D O I
10.1074/jbc.M107430200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The adamalysins (ADAMS) are transmembrane glycoproteins involved in cell adhesion and proteolytic ectodomain processing of cytokines and adhesion molecules. Many ADAM cytoplasmic domains are proline-rich and have potential phosphorylation sites. We show here that the cytoplasmic domain of ADAM15, metargidin, can interact specifically with Src family protein-tyrosine kinases (PTKs) and the adaptor protein Grb2 in hematopoietic cells (Jurkat, THP-1, U937, and K562 cell lines). Src homology 3 domains from several Src family PTKs including Lek, Fyn, Abl, and Src associate with ADAM15 in vitro. Dephosphorylation of cell extracts resulted in decreased association of ADAM15 with Src family PTK SH3 domains, indicating that phosphorylation influences ADAM15 interactions with its binding partners. This was confirmed in vitro for Hck, Lek, and Grb2, which showed enhanced association with tyrosine-phosphorylated glutathione S-transferase-ADAM15 cytoplasmic domain compared with unphosphorylated protein. In contrast, binding of MAD2 to ADAM15 was slightly reduced by phosphorylation of the ADAM. Immunoprecipitation of ADAM15 from Jurkat cells confirmed the association with Lek in vivo, and upon PMA stimulation, the phosphorylation level of ADAM15 was increased. Cotransfection of ADAM15 and Hck showed Hck-dependent phosphorylation of ADAM15 in vivo. Hck, and to a lesser extent Lek, phosphorylated the ADAM15 cytoplasmic domain in vitro in immune complex kinase assays. Binding of ADAM15 cytoplasmic domain to Hck and Lek was also shown by Far Western analysis. In contrast to Hck, Lek activity was not required for binding to ADAM15, as shown by treatment of cells with PP1. Deletion and point mutation analysis of the ADAM15 cytoplasmic domain confirmed the importance of the proline-rich motifs for Grb2 and Lek binding and indicated the regulatory nature of Tyr(715) and Tyr(735) These data demonstrate selective, phosphorylation-dependent interactions of ADAM15 with Src family PTKs and Grb2, which highlight the potential for integration of ADAM functions and cellular signaling.
引用
收藏
页码:4999 / 5007
页数:9
相关论文
共 50 条
[1]   Xenopus ADAM 13 is a metalloprotease required for cranial neural crest-cell migration [J].
Alfandari, D ;
Cousin, H ;
Gaultier, A ;
Smith, K ;
White, JM ;
Darribère, T ;
DeSimone, DW .
CURRENT BIOLOGY, 2001, 11 (12) :918-930
[2]   The unique N-terminal domain of the cAMP phosphodiesterase PDE4D4 allows for interaction with specific SH3 domains [J].
Beard, MB ;
O'Connell, JC ;
Bolger, GB ;
Houslay, MD .
FEBS LETTERS, 1999, 460 (01) :173-177
[3]   A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells [J].
Black, RA ;
Rauch, CT ;
Kozlosky, CJ ;
Peschon, JJ ;
Slack, JL ;
Wolfson, MF ;
Castner, BJ ;
Stocking, KL ;
Reddy, P ;
Srinivasan, S ;
Nelson, N ;
Boiani, N ;
Schooley, KA ;
Gerhart, M ;
Davis, R ;
Fitzner, JN ;
Johnson, RS ;
Paxton, RJ ;
March, CJ ;
Cerretti, DP .
NATURE, 1997, 385 (6618) :729-733
[4]   ADAMs: focus on the protease domain [J].
Black, RA ;
White, JM .
CURRENT OPINION IN CELL BIOLOGY, 1998, 10 (05) :654-659
[5]   Remarkable roles of proteolysis on and beyond the cell surface [J].
Blobel, CP .
CURRENT OPINION IN CELL BIOLOGY, 2000, 12 (05) :606-612
[6]   New hope for matrix metalloproteinase inhibitors in cancer therapy [J].
Brown, PD .
DRUG DISCOVERY TODAY, 2001, 6 (12) :615-615
[7]  
CAO HY, 2001, BIOCHEM J, V357, P353
[8]   Urokinase receptor-dependent and -independent p56/59hck activation state is a molecular switch between myelomonocytic cell motility and adherence [J].
Chiaradonna, F ;
Fontana, L ;
Iavarone, C ;
Carriero, MV ;
Scholz, G ;
Barone, MV ;
Stoppelli, MP .
EMBO JOURNAL, 1999, 18 (11) :3013-3023
[9]  
Codony-Servat J, 1999, CANCER RES, V59, P1196
[10]   PACSIN2 is a regulator of the metalloprotease/disintegrin ADAM13 [J].
Cousin, H ;
Gaultier, A ;
Bleux, C ;
Darribère, T ;
Alfandari, D .
DEVELOPMENTAL BIOLOGY, 2000, 227 (01) :197-210